UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bayesian Designs for Phase I-II Clinical Trials

1, 2017

Volltextzugriff (PDF)

Aircraft Trajectory Prediction With Enriched Intent Using Encoder-Decoder Architecture

IEEE access, 2022, Vol.10, p.17881-17896

2022

Volltextzugriff (PDF)

Using Joint Utilities of the Times to Response and Toxicity to Adaptively Optimize Schedule-Dose Regimes

Biometrics, 2013-09, Vol.69 (3), p.673-682

2013

Volltextzugriff (PDF)

Optimizing Sedative Dose in Preterm Infants Undergoing Treatment for Respiratory Distress Syndrome

Journal of the American Statistical Association, 2014-09, Vol.109 (507), p.931-943

2014

Volltextzugriff (PDF)

Genome-wide identification and expression profiling of duplicated flavonoid 3'-hydroxylase gene family in Carthamus tinctorius L

Notulae botanicae Horti agrobotanici Cluj-Napoca, 2021-01, Vol.49 (4), p.12509

2021

Volltextzugriff (PDF)

Equal-Channel Angular Extrusion of a Low-Density High-Entropy Alloy Produced by High-Energy Cryogenic Mechanical Alloying

JOM (1989), 2014-10, Vol.66 (10), p.2021-2029

2014

Volltextzugriff (PDF)

Genome-wide investigation of Hydroxycinnamoyl CoA: Shikimate Hydroxycinnamoyl Transferase (HCT) gene family in Carthamus tinctorius L

Notulae botanicae Horti agrobotanici Cluj-Napoca, 2021-01, Vol.49 (3), p.12489

2021

Volltextzugriff (PDF)

Patient-Specific Dose Finding Based on Bivariate Outcomes and Covariates

Biometrics, 2008-12, Vol.64 (4), p.1126-1136

2008

Volltextzugriff (PDF)

Effective sample size for computing prior hyperparameters in Bayesian phase I–II dose-finding

Clinical trials (London, England), 2014-12, Vol.11 (6), p.657-666

2014

Volltextzugriff (PDF)

Maintenance Therapy With Low-Dose Azacitidine After Allogeneic Hematopoietic Stem Cell Transplantation for Recurrent Acute Myelogenous Leukemia or Myelodysplastic Syndrome: A Dose and Schedule Finding Study

Cancer, 2010-12, Vol.116 (23), p.5420-5431

2010

Volltextzugriff (PDF)

Adaptive Randomization to Improve Utility-Based Dose-Finding with Bivariate Ordinal Outcomes

Journal of biopharmaceutical statistics, 2012-07, Vol.22 (4), p.785-801

2012

Volltextzugriff (PDF)

Perforated appendicitis due to fishbone

Journal of surgical case reports, 2024-01, Vol.2024 (1), p.rjad694

2024

Volltextzugriff (PDF)

Parametric dose standardization for optimizing two-agent combinations in a phase I-II trial with ordinal outcomes

Journal of the Royal Statistical Society Series C: Applied Statistics, 2017-01, Vol.66 (1), p.201-224

2017

Volltextzugriff (PDF)

Glaucoma in Microspherophakia: Presenting Features and Treatment Outcomes

Journal of glaucoma, 2014-04, Vol.23 (4), p.262-267

2014

Volltextzugriff (PDF)

A hybrid geometric phase II/III clinical trial design based on treatment failure time and toxicity

Journal of statistical planning and inference, 2012-04, Vol.142 (4), p.944-955

2012

Volltextzugriff (PDF)

Maintenance therapy with low‐dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome

Cancer, 2010-12, Vol.116 (23), p.5420-5431

2010

Volltextzugriff (PDF)

Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia

Haematologica (Roma), 2015-07, Vol.100 (7), p.927-934

2015

Volltextzugriff (PDF)

A Hierarchical Bayesian IRT Analysis of Children's Risk Propensity

2020 19th IEEE International Conference on Machine Learning and Applications (ICMLA), 2020, p.942-947

2020

Volltextzugriff (PDF)

Molecular dynamics modeling of the thermal conductivity of irradiated SiC as a function of cascade overlap

Journal of applied physics, 2007-01, Vol.101 (2), p.023527-023527-5

2007

Volltextzugriff (PDF)

Effective sample size for computing prior hyperarameters in Bayesian phase I-II dose-finding

Clinical trials (London, England), 2014-09, Vol.11 (6), p.657-666

2014

Volltextzugriff (PDF)

Final report of phase I/II study of PR104, a hypoxia-activated pro-drug, in relapsed/refractory acute leukemia

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.7074-7074

2013

Volltextzugriff (PDF)

Verification of Box Test Model and Calibration of Finite Element Model: Evaluation of Railroad Ballast Performance: Railways 2011: Including 2011 Thomas B. Deen Distinguished Lecture

Transportation research record, 2011 (2261), p.171-177

2011

Volltextzugriff (PDF)

Phase I/II Study of PR104, a Bioreductive Prodrug, in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) Using Patient-Specific Adaptive Dose Selection

Blood, 2011-11, Vol.118 (21), p.1523-1523

2011

Volltextzugriff (PDF)

Verification of Box Test Model and Calibration of Finite Element Model: Evaluation of Railroad Ballast Performance

Transportation research record, 2011-01, Vol.2261 (1), p.171-177

2011

Volltextzugriff (PDF)

Optimizing Dose and Schedule

Bayesian Designs for Phase I-II Clinical Trials, 2016, p.223-244

1, 2016

Volltextzugriff (PDF)

1 – 25 von 730

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(548)
Mit Volltextzugriff
(650)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(427)
Life Sciences & Biomedicine
(240)
Technology
(136)
Humans
(132)
Vietnam
(109)
Engineering
(87)
Physical Sciences
(86)
Female
(83)
Male
(72)
Adult
(63)
Engineering, Electrical & Electronic
(61)
Vietnam - Epidemiology
(48)
Infectious Diseases
(47)
Middle Aged
(46)
Computer Science
(38)
Telecommunications
(38)
Optimization
(37)
Public, Environmental & Occupational Health
(35)
Hospitals
(34)
Physics
(33)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

Bayesian Designs for Phase I-II Clinical Trials

Aircraft Trajectory Prediction With Enriched Intent Using Encoder-Decoder Architecture

Using Joint Utilities of the Times to Response and Toxicity to Adaptively Optimize Schedule-Dose Regimes

Optimizing Sedative Dose in Preterm Infants Undergoing Treatment for Respiratory Distress Syndrome

Genome-wide identification and expression profiling of duplicated flavonoid 3'-hydroxylase gene family in Carthamus tinctorius L

Equal-Channel Angular Extrusion of a Low-Density High-Entropy Alloy Produced by High-Energy Cryogenic Mechanical Alloying

Genome-wide investigation of Hydroxycinnamoyl CoA: Shikimate Hydroxycinnamoyl Transferase (HCT) gene family in Carthamus tinctorius L

Patient-Specific Dose Finding Based on Bivariate Outcomes and Covariates

Effective sample size for computing prior hyperparameters in Bayesian phase I–II dose-finding

Maintenance Therapy With Low-Dose Azacitidine After Allogeneic Hematopoietic Stem Cell Transplantation for Recurrent Acute Myelogenous Leukemia or Myelodysplastic Syndrome: A Dose and Schedule Finding Study

Adaptive Randomization to Improve Utility-Based Dose-Finding with Bivariate Ordinal Outcomes

Perforated appendicitis due to fishbone

Parametric dose standardization for optimizing two-agent combinations in a phase I-II trial with ordinal outcomes

Glaucoma in Microspherophakia: Presenting Features and Treatment Outcomes

A hybrid geometric phase II/III clinical trial design based on treatment failure time and toxicity

Maintenance therapy with low‐dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome

Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia

A Hierarchical Bayesian IRT Analysis of Children's Risk Propensity

Molecular dynamics modeling of the thermal conductivity of irradiated SiC as a function of cascade overlap

Effective sample size for computing prior hyperarameters in Bayesian phase I-II dose-finding

Final report of phase I/II study of PR104, a hypoxia-activated pro-drug, in relapsed/refractory acute leukemia

Verification of Box Test Model and Calibration of Finite Element Model: Evaluation of Railroad Ballast Performance: Railways 2011: Including 2011 Thomas B. Deen Distinguished Lecture

Phase I/II Study of PR104, a Bioreductive Prodrug, in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) Using Patient-Specific Adaptive Dose Selection

Verification of Box Test Model and Calibration of Finite Element Model: Evaluation of Railroad Ballast Performance

Optimizing Dose and Schedule

Suchergebnisse filtern